期刊文献+

miR-200b在结直肠癌组织中的表达情况及临床意义 被引量:2

Expression and clinical significance of miR-200b in colorectal cancer
下载PDF
导出
摘要 目的探讨miR-200b在结直肠癌组织中的表达情况及其与患者临床病理特征的关系。方法采用实时定量PCR分析结直肠癌组织与癌旁正常组织中miR-200b的表达的差异;按ΔΔCT法对目的基因进行相对定量,结直肠癌组织中的miR-200b表达低于相应癌旁正常结直肠组织,则视为低表达,反之则为高表达;将80例结直肠癌组织按miR-200b表达情况分为高表达和低表达,分析miR-200b的表达情况与患者临床资料、病理参数之间的关系。结果结直肠组织中miR-200b表达水平明显低于癌旁正常组织(P<0.01);结直肠癌组织miR-200b的低表达率在不同性别、年龄、肿瘤部位患者间的差异均无统计学意义(P>0.05);miR-200b的表达水平降低与组织学分级、TNM分期、血清CEA水平密切相关。结论 miR-200b很可能会成为结直肠癌早期诊断及预后判断的指标。 Objective To study the expression of miR-200b in colorectal cancer and its correlation with clinical features and pathological characters.Methods To detect the expression of miR-200b in colon cancer tissues and corresponding normal tissues by qPCR,and relatively quantify the level of target gene by ΔΔCT method.The expression level of miR-200b in colorectal cancer tissue is lower than corresponding adjacent normal colorectal tissue,which is regarded as a low expression,otherwise is regarded as high expression.80 colorectal cancer tissue samples were judged as high expression or low expression,then the comparison of miR-200b expresson were did among patients with different clinical features and pathological parameters.Results miR-200b expression level in the colorectal cancer tissue was significantly lower than the corresponding adjacent normal colorectal tissue(P&lt;0.01).Decreased miR-200b expression rates of colorectal cancer tissue showed no significant difference in different clinical features,such as sex,age and tumor site(P&gt;0.05).However,the decreased expression rates of miR-200b were obviously related with pathological grade of colorectal cancer,TNM stages and serum CEA level.Conclusion miR-200b may become a new tumor marker in the early diagnosis and prognosis of colorectal cancer.
出处 《国际检验医学杂志》 CAS 2013年第16期2095-2096,2098,共3页 International Journal of Laboratory Medicine
关键词 结直肠肿瘤 微RNAS 聚合酶链反应 colorectal neoplasms microRNAs polymerase chain reaction
  • 相关文献

参考文献12

  • 1Motoyama K, Inoue H, Takatsuno Y, et al. Over- and under-ex pressed mieroRNAs in human eolorectal Cance[J]. lnt J Oneol 2009,34(4) :1069 1075.
  • 2Wang C J, Zhou ZG,Wang L, et al. Clinicopathological significance of microRNA-31,-143 and -145 expression in colorectal Cancer [J]. Dis Markers,2009,26(1) 27-34.
  • 3Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin 4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993,75(5) ,843-854.
  • 4Stark A, Brennecke J, Bushati N, et al. Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3r UTR evolution[J]. Ce11,2005,123(6) :1133-1146.
  • 5Kurashige J, Kamohara H, Watanabe M, et al. MicroRNA-200b regulates cell proliferation,invasion, and migration by directly tar geting ZEB2 in gastric carcinoma[M]. Ann Surg Oncol, 2012,19 (Suppl 3) :$656-$664.
  • 6Tryndyak VP,Ross SA,Beland FA, et al. Down-regulation of the microRNAs miR-34a, miR-127, and miR 200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet[J]. Mol Carcinog, 2009,48 (6) : 479-487.
  • 7Hu X,Macdonald DM,Huettner PC,et al. A miR 200 microRNA cluster as prognostic marker in advanced ovarian Cancer[J]. Gy-necol Oncol, 2009,114 (3) : 457-464.
  • 8Gregory PA, Bert AG, Paterson EL, et al. The miR 200 family and miR 205 regulate epithelial to mesenchymal transition by targe- ting ZEB1 and SIPI[J]. Nat Cell Biol,2008,10(5):593 601.
  • 9Wszolek MF, Rieger-Christ KM, Kenney PA, et al. A MicroRNA expression profile defining the invasive bladder tumor phenotype [J]. Urol Oncol,2011,29(6) :794 801.
  • 10AI-Ahwal MS,Shafik YH, AI-Ahwal HM. First National survival data for colorectal Cancer among Saudis between 1994 and 2004: what's next[J]. BMC Public Health,2013,13(1) :73.

同被引文献22

  • 1Akagi Y, Adachi Y, Kinugasa T, et al. Lymph node evaluation and sur- vival in colorectal cancer: review of population-based, prospective stud- ies [ J ]. Anticancer Res, 2013,33 ( 7 ) : 2839 -2847.
  • 2Abba M, Benner A, Patil N, et al. Differentially expressed microRNAs in colorectal cancer metastasis[J]. Genom Data,2015,5(6) :33-35.
  • 3Dhayat SA, Abdeen B, Ktihler G, et al. MicroRNA-100 and microRNA-21 as nmrkers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II [ J]. Clin Epigenetics, 2015, 23 ( 7 ) : 132-132.
  • 4Ye F, Tang H, Liu Q, et al. miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family [ J ]. J Transl Meal, 2014,12(17) :1-10.
  • 5Bai WD ,Ye XM ,Zhang MY ,et al. MiR-200c suppresses TGFq3 signa- ling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer[ J]. Int J Cancer,2014,135 (6) : 1356-1368.
  • 6Chang L, Guo F, Huo B, et al. Expression and clinical significance of the microRNA-200 family in gastric cancer [ J]. Oncol Lett, 2015,9 (5) :2317-2324.
  • 7Tanaka S, Husokawa M, Yonezawa T, et al. Induction of epithelial-mes- enchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells[ J]. Biol Pharm Bull ,2015, 38(3) :435-440.
  • 8Radisky DC. miR-200c at the nexus of epithelial-mesenchymal transi- tion,resistance to apoptosis, and the breast cancer stem cell phenotype [J]. Breast Cancer Res,2011,13(3) :110-111.
  • 9Tang H, Deng M ,Tang Y, et al. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression [ J ]. Clin Cancer Res,2013,19(20) :5602-5612.
  • 10Xi Chen,Yi Ba,Lijia Ma,Xing Cai,Yuan Yin,Kehui Wang,Jig ang Guo,Yujing Zhang,Jiangning Chen,Xing Guo,Qibin Li,Xiaoying Li,Wenjing Wang,Yan Zhang,Jin Wang,Xueyuan Jiang,Yang Xiang,Chen Xu,Pingping Zheng,Juanbin Zhang,Ruiqiang Li,Hongjie Zhang,Xiaobin Shang,Ting Gong,Guang Ning,Jun Wang,Ke Zen,Junfeng Zhang,Chen-Yu Zhang.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Research,2008,18(10):997-1006. 被引量:982

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部